Ur-Energy Reports FY Loss, Stock Drops 13%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 12 hours ago
0mins
Should l Buy URG?
Source: seekingalpha
- Earnings Loss: Ur-Energy reported a FY GAAP EPS of -$0.20, indicating significant challenges in profitability and reflecting pressure in market competition.
- Revenue Decline: The company generated $27.21 million in revenue, a 19.3% year-over-year decrease, missing expectations by $0.66 million, suggesting difficulties in business growth that could impact future investor confidence.
- Stock Price Volatility: Ur-Energy's stock dropped 13%, reflecting the market's negative reaction to its financial performance, potentially leading investors to reassess its investment value.
- Convertible Notes Issuance: The company plans to issue $100 million in convertible notes to raise funds for future development, but this move may dilute existing shareholders' equity and increase market uncertainty.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy URG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on URG
Wall Street analysts forecast URG stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.440
Low
2.00
Averages
2.31
High
2.60
Current: 1.440
Low
2.00
Averages
2.31
High
2.60
About URG
Ur-Energy Inc. is a uranium mining company. The Company is engaged in uranium mining, recovery and processing activities, including the acquisition, exploration, development and operation of uranium mineral properties in the United States. The Company has produced and packaged approximately 2.9 million pounds of U3O8 from Lost Creek. Its land portfolio in Wyoming includes 12 projects. 10 of these projects are in the Great Divide Basin (GDB), Wyoming, including its flagship project, Lost Creek Project. It controls nearly 1,800 unpatented mining claims and three State of Wyoming mineral leases for a total of approximately 35,400 acres at its Lost Creek Property, including the Lost Creek permit area (the Lost Creek Project or Lost Creek). Five of the projects at the Lost Creek Property contain reported mineral resources: Lost Creek, LC East, LC West, LC South and LC North. Its Wyoming properties together total approximately 48,000 acres and include its Shirley Basin Project.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ur-Energy Reports FY Loss, Stock Drops 13%
- Earnings Loss: Ur-Energy reported a FY GAAP EPS of -$0.20, indicating significant challenges in profitability and reflecting pressure in market competition.
- Revenue Decline: The company generated $27.21 million in revenue, a 19.3% year-over-year decrease, missing expectations by $0.66 million, suggesting difficulties in business growth that could impact future investor confidence.
- Stock Price Volatility: Ur-Energy's stock dropped 13%, reflecting the market's negative reaction to its financial performance, potentially leading investors to reassess its investment value.
- Convertible Notes Issuance: The company plans to issue $100 million in convertible notes to raise funds for future development, but this move may dilute existing shareholders' equity and increase market uncertainty.
See More
Trump Positions Nuclear Energy as Key to US Manufacturing Growth
- Nuclear Sector Rally: Following Trump's address at the World Economic Forum framing nuclear energy as a safe and efficient solution, nuclear stocks surged, indicating strong market confidence in the sector.
- Policy Initiatives: The executive orders mentioned by Trump aim to streamline nuclear reactor licensing and fast-track small modular reactors (SMRs), which are expected to further solidify the U.S. position as an energy superpower.
- Investor Enthusiasm: Stocks of companies like Oklo, Nano Nuclear Energy, and NuScale Power spiked in response to Trump's support for nuclear power, reflecting investor optimism in the nuclear industry.
- Economic Confidence: Trump asserted that the U.S. is the economic engine of the world, with all three major indexes rising, including a 0.32% increase in the S&P 500, showcasing market confidence in the recovery of the American economy.
See More
Uranium and Nuclear-Related Stocks Rise Following President Trump's Remarks on Nuclear Energy at Davos Meeting
Uranium and Nuclear Stocks Surge: Shares of uranium and nuclear-linked stocks are experiencing a rise in trading activity.
Trump's Remarks at Davos: During the Davos meeting, President Trump emphasized the United States' strong commitment to nuclear energy.
See More
Direxion Daily S&P 500 Bull 3X ETF Drops 3.1%, Applovin Falls 9.4%
- ETF Underperformance: The Direxion Daily S&P 500 Bull 3X ETF is down approximately 3.1% in Wednesday afternoon trading, indicating a decline in investor confidence that may affect short-term investment decisions.
- Component Stocks Decline: Within the ETF, Applovin shares fell about 9.4%, while Intuit dropped around 7.2%, reflecting poor market performance that could lead investors to reassess their future growth potential.
- Market Sentiment Fluctuation: The overall decline of the ETF, combined with the weak performance of its components, may raise investor concerns about tech stocks, potentially impacting capital flows and investment strategies in related sectors.
- Investor Reaction: As the Direxion ETF underperforms, investors might consider adjusting their portfolios towards more stable assets to navigate market uncertainties and volatility.
See More
U.S. Stocks Rise on Venezuela Action; Chevron Shares Up 5.8%
- Market Rally: U.S. equities wrapped the first full trading week of 2026 on a strong note, with both the S&P 500 and Dow Jones Industrial Average reaching new record highs, reflecting investor optimism about economic recovery.
- Energy Stocks Surge: Following U.S. military actions in Venezuela, Chevron shares rose approximately 5.8%, as investors expressed optimism about potential access to the country's oil resources, highlighting the direct impact of geopolitical events on market performance.
- Defense Stocks Rise: Anticipation of a significantly larger Pentagon budget in 2027 led to substantial gains for defense contractors, indicating a strong market focus on defense spending and confidence in future growth prospects.
- Mixed Economic Data: The December jobs report revealed slower-than-expected payroll growth but a declining unemployment rate, easing investor concerns about labor market stress and supporting the narrative that the Fed may hold rates steady in the near term.
See More
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
See More
Ur-Energy Reports FY Loss, Stock Drops 13%
- Earnings Loss: Ur-Energy reported a FY GAAP EPS of -$0.20, indicating significant challenges in profitability and reflecting pressure in market competition.
- Revenue Decline: The company generated $27.21 million in revenue, a 19.3% year-over-year decrease, missing expectations by $0.66 million, suggesting difficulties in business growth that could impact future investor confidence.
- Stock Price Volatility: Ur-Energy's stock dropped 13%, reflecting the market's negative reaction to its financial performance, potentially leading investors to reassess its investment value.
- Convertible Notes Issuance: The company plans to issue $100 million in convertible notes to raise funds for future development, but this move may dilute existing shareholders' equity and increase market uncertainty.
See More
Trump Positions Nuclear Energy as Key to US Manufacturing Growth
- Nuclear Sector Rally: Following Trump's address at the World Economic Forum framing nuclear energy as a safe and efficient solution, nuclear stocks surged, indicating strong market confidence in the sector.
- Policy Initiatives: The executive orders mentioned by Trump aim to streamline nuclear reactor licensing and fast-track small modular reactors (SMRs), which are expected to further solidify the U.S. position as an energy superpower.
- Investor Enthusiasm: Stocks of companies like Oklo, Nano Nuclear Energy, and NuScale Power spiked in response to Trump's support for nuclear power, reflecting investor optimism in the nuclear industry.
- Economic Confidence: Trump asserted that the U.S. is the economic engine of the world, with all three major indexes rising, including a 0.32% increase in the S&P 500, showcasing market confidence in the recovery of the American economy.
See More
Uranium and Nuclear-Related Stocks Rise Following President Trump's Remarks on Nuclear Energy at Davos Meeting
Uranium and Nuclear Stocks Surge: Shares of uranium and nuclear-linked stocks are experiencing a rise in trading activity.
Trump's Remarks at Davos: During the Davos meeting, President Trump emphasized the United States' strong commitment to nuclear energy.
See More
Direxion Daily S&P 500 Bull 3X ETF Drops 3.1%, Applovin Falls 9.4%
- ETF Underperformance: The Direxion Daily S&P 500 Bull 3X ETF is down approximately 3.1% in Wednesday afternoon trading, indicating a decline in investor confidence that may affect short-term investment decisions.
- Component Stocks Decline: Within the ETF, Applovin shares fell about 9.4%, while Intuit dropped around 7.2%, reflecting poor market performance that could lead investors to reassess their future growth potential.
- Market Sentiment Fluctuation: The overall decline of the ETF, combined with the weak performance of its components, may raise investor concerns about tech stocks, potentially impacting capital flows and investment strategies in related sectors.
- Investor Reaction: As the Direxion ETF underperforms, investors might consider adjusting their portfolios towards more stable assets to navigate market uncertainties and volatility.
See More
U.S. Stocks Rise on Venezuela Action; Chevron Shares Up 5.8%
- Market Rally: U.S. equities wrapped the first full trading week of 2026 on a strong note, with both the S&P 500 and Dow Jones Industrial Average reaching new record highs, reflecting investor optimism about economic recovery.
- Energy Stocks Surge: Following U.S. military actions in Venezuela, Chevron shares rose approximately 5.8%, as investors expressed optimism about potential access to the country's oil resources, highlighting the direct impact of geopolitical events on market performance.
- Defense Stocks Rise: Anticipation of a significantly larger Pentagon budget in 2027 led to substantial gains for defense contractors, indicating a strong market focus on defense spending and confidence in future growth prospects.
- Mixed Economic Data: The December jobs report revealed slower-than-expected payroll growth but a declining unemployment rate, easing investor concerns about labor market stress and supporting the narrative that the Fed may hold rates steady in the near term.
See More
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
See More
